This combination inhalation powder contains Glycopyrronium 25 mcg, Formoterol Fumarate 12 mcg, and Budesonide 400 mcg. It is specifically formulated for the management of chronic obstructive pulmonary disease (COPD) and asthma in adults. Glycopyrronium is a long-acting muscarinic antagonist (LAMA) that helps relax airway muscles, reducing bronchoconstriction. Formoterol Fumarate is a long-acting beta-2 agonist (LABA) that aids in bronchodilation, making breathing easier. Budesonide is an inhaled corticosteroid (ICS) that reduces airway inflammation and prevents exacerbations. This triple therapy provides symptom relief, improved lung function, and reduced risk of asthma or COPD flare-ups when used as prescribed. It is delivered via a dry powder inhaler (DPI) for targeted delivery to the lungs.
